[HTML][HTML] Hepatic mitochondrial reductive stress in the pathogenesis and treatment of steatotic liver disease
MJ Jokinen, PK Luukkonen - Trends in Pharmacological Sciences - cell.com
Steatotic liver diseases (SLDs) affect one-third of the population, but the pathogenesis
underlying these diseases is not well understood, limiting the available treatments. A …
underlying these diseases is not well understood, limiting the available treatments. A …
[PDF][PDF] Hepatic mitochondrial reductive stress in the pathogenesis and treatment of steatotic liver disease
MJ Jokinen, PK Luukkonen - 2024 - helda.helsinki.fi
Steatotic liver diseases (SLDs) affect one-third of the population, but the pathogenesis
underlying these diseases is not well understood, limiting the available treatments. A …
underlying these diseases is not well understood, limiting the available treatments. A …
[HTML][HTML] Hepatic mitochondrial reductive stress in the pathogenesis and treatment of steatotic liver disease
MJ Jokinen, PK Luukkonen - Trends in Pharmacological Sciences, 2024 - Elsevier
Steatotic liver diseases (SLDs) affect one-third of the population, but the pathogenesis
underlying these diseases is not well understood, limiting the available treatments. A …
underlying these diseases is not well understood, limiting the available treatments. A …
Hepatic mitochondrial reductive stress in the pathogenesis and treatment of steatotic liver disease
MJ Jokinen, PK Luukkonen - Trends in pharmacological … - pubmed.ncbi.nlm.nih.gov
Steatotic liver diseases (SLDs) affect one-third of the population, but the pathogenesis
underlying these diseases is not well understood, limiting the available treatments. A …
underlying these diseases is not well understood, limiting the available treatments. A …
Hepatic mitochondrial reductive stress in the pathogenesis and treatment of steatotic liver disease
MJ Jokinen, PK Luukkonen - Trends in Pharmacological …, 2024 - researchportal.helsinki.fi
Steatotic liver diseases (SLDs) affect one-third of the population, but the pathogenesis
underlying these diseases is not well understood, limiting the available treatments. A …
underlying these diseases is not well understood, limiting the available treatments. A …
Hepatic mitochondrial reductive stress in the pathogenesis and treatment of steatotic liver disease.
MJ Jokinen, PK Luukkonen - Trends in Pharmacological Sciences, 2024 - europepmc.org
Steatotic liver diseases (SLDs) affect one-third of the population, but the pathogenesis
underlying these diseases is not well understood, limiting the available treatments. A …
underlying these diseases is not well understood, limiting the available treatments. A …
Hepatic mitochondrial reductive stress in the pathogenesis and treatment of steatotic liver disease
MJ Jokinen, PK Luukkonen - 2024 - helda.helsinki.fi
Steatotic liver diseases (SLDs) affect one-third of the population, but the pathogenesis
underlying these diseases is not well understood, limiting the available treatments. A …
underlying these diseases is not well understood, limiting the available treatments. A …